PAR DRUGS AND CHEMICALS
Back to Balance Sheet
|
PAR DRUGS AND CHEMICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹3.85 Cr | ₹3.54 Cr | ₹3.64 Cr | ₹3.96 Cr | ₹8.19 Cr |
What is the latest Total Non-Current Liabilities ratio of PAR DRUGS AND CHEMICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹3.85 Cr |
| Mar2024 | ₹3.54 Cr |
| Mar2023 | ₹3.64 Cr |
| Mar2022 | ₹3.96 Cr |
| Mar2021 | ₹8.19 Cr |
How is Total Non-Current Liabilities of PAR DRUGS AND CHEMICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.85 Cr | 8.67 | |
| Mar2024 | ₹3.54 Cr | -2.75 | |
| Mar2023 | ₹3.64 Cr | -7.99 | |
| Mar2022 | ₹3.96 Cr | -51.70 | |
| Mar2021 | ₹8.19 Cr | - | |
Compare Total Non-Current Liabilities of peers of PAR DRUGS AND CHEMICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PAR DRUGS AND CHEMICALS | ₹112.5 Cr | 1.5% | 1.8% | -5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
PAR DRUGS AND CHEMICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PAR DRUGS AND CHEMICALS | 1.5% |
1.8% |
-5.2% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses